Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M422Revenue (TTM) $M0.2Net Margin (%)-48,979.1Altman Z-Score1.8
Enterprise Value $M380EPS (TTM) $-1.4Operating Margin %-49,521.5Piotroski F-Score1
P/E(ttm)--Beneish M-Score-4.7Pre-tax Margin (%)-48,977.9Higher ROA y-yN
Price/Book7.010-y EBITDA Growth Rate %-18.3Quick Ratio3.3Cash flow > EarningsY
Price/Sales1,7385-y EBITDA Growth Rate %6.0Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-89.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M60.8ROIC % (ttm)-512.4Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 6.95-47%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 6.95-60%New holding44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-13.13view
Myszkowski Kenneth AllenCFO 2016-08-23Sell20,000$8-13.13view
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.1313.38view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-13.23view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.329.97view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.329.97view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-52.72view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-53.73view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-54.4view
GIVEN DOUGLAS BDirector 2014-08-15Sell5,000$13.9-50view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
Arrowhead (ARWR) Exited Third Quarter with a Strong Balance Sheet Aug 23 2016
ETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 19, 2016 Aug 19 2016
ARROWHEAD PHARMACEUTICALS, INC. Financials Aug 18 2016
Coverage initiated on Arrowhead by Cantor Fitzgerald Aug 18 2016
Arrowhead Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARWR-US :... Aug 15 2016
Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2016 By the Numbers : August 12,... Aug 12 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering Aug 12 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering Aug 12 2016
ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other... Aug 10 2016
Edited Transcript of ARWR earnings conference call or presentation 9-Aug-16 8:30pm GMT Aug 09 2016
Arrowhead Reports Fiscal 2016 Third Quarter Results Aug 09 2016
Arrowhead Research reports 3Q loss Aug 09 2016
Arrowhead Research reports 3Q loss Aug 09 2016
ARROWHEAD PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 09 2016
Arrowhead Reports Fiscal 2016 Third Quarter Results Aug 09 2016
Arrowhead Pharmaceuticals Prices $45 Million Private Offering Aug 09 2016
Arrowhead Pharmaceuticals Prices $45 Million Private Offering Aug 09 2016
Q3 2016 Arrowhead Pharmaceuticals Inc Earnings Release - After Market Close Aug 09 2016
ETF’s with exposure to Arrowhead Pharmaceuticals, Inc. : August 8, 2016 Aug 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)